96 related articles for article (PubMed ID: 28104390)
1. Progesterone and VIP cross-talk enhances phagocytosis and anti-inflammatory profile in trophoblast-derived cells.
Vota D; Aguero M; Grasso E; Hauk V; Gallino L; Soczewski E; Pérez Leirós C; Ramhorst R
Mol Cell Endocrinol; 2017 Mar; 443():146-154. PubMed ID: 28104390
[TBL] [Abstract][Full Text] [Related]
2. Trophoblast cells inhibit neutrophil extracellular trap formation and enhance apoptosis through vasoactive intestinal peptide-mediated pathways.
Calo G; Sabbione F; Vota D; Paparini D; Ramhorst R; Trevani A; Pérez Leirós C
Hum Reprod; 2017 Jan; 32(1):55-64. PubMed ID: 27932441
[TBL] [Abstract][Full Text] [Related]
3. Contribution of vasoactive intestinal peptide to immune homeostasis in trophoblast-maternal leukocyte interaction under LPS stimulation.
Fraccaroli L; Grasso E; Hauk V; Cortelezzi M; Pérez Leirós C; Ramhorst R
Neuroimmunomodulation; 2014; 21(1):21-30. PubMed ID: 24135863
[TBL] [Abstract][Full Text] [Related]
4. Trophoblast cells primed with vasoactive intestinal peptide enhance monocyte migration and apoptotic cell clearance through αvβ3 integrin portal formation in a model of maternal-placental interaction.
Paparini D; Grasso E; Calo G; Vota D; Hauk V; Ramhorst R; Leirós CP
Mol Hum Reprod; 2015 Dec; 21(12):930-41. PubMed ID: 26502804
[TBL] [Abstract][Full Text] [Related]
5. Vasoactive Intestinal Peptide modulates trophoblast-derived cell line function and interaction with phagocytic cells through autocrine pathways.
Vota D; Paparini D; Hauk V; Toro A; Merech F; Varone C; Ramhorst R; Pérez Leirós C
Sci Rep; 2016 May; 6():26364. PubMed ID: 27212399
[TBL] [Abstract][Full Text] [Related]
6. VIP modulates the pro-inflammatory maternal response, inducing tolerance to trophoblast cells.
Fraccaroli L; Alfieri J; Larocca L; Calafat M; Roca V; Lombardi E; Ramhorst R; Leirós CP
Br J Pharmacol; 2009 Jan; 156(1):116-26. PubMed ID: 19133995
[TBL] [Abstract][Full Text] [Related]
7. VIP boosts regulatory T cell induction by trophoblast cells in an in vitro model of trophoblast-maternal leukocyte interaction.
Fraccaroli L; Grasso E; Hauk V; Paparini D; Soczewski E; Mor G; Pérez Leirós C; Ramhorst R
J Leukoc Biol; 2015 Jul; 98(1):49-58. PubMed ID: 25877932
[TBL] [Abstract][Full Text] [Related]
8. Defects in the vasoactive intestinal peptide (VIP)/VPAC system during early stages of the placental-maternal leucocyte interaction impair the maternal tolerogenic response.
Fraccaroli L; Grasso E; Hauk V; Cortelezzi M; Calo G; Pérez Leirós C; Ramhorst R
Clin Exp Immunol; 2012 Dec; 170(3):310-20. PubMed ID: 23121672
[TBL] [Abstract][Full Text] [Related]
9. Monocytes from Sjögren's syndrome patients display increased vasoactive intestinal peptide receptor 2 expression and impaired apoptotic cell phagocytosis.
Hauk V; Fraccaroli L; Grasso E; Eimon A; Ramhorst R; Hubscher O; Pérez Leirós C
Clin Exp Immunol; 2014 Sep; 177(3):662-70. PubMed ID: 24827637
[TBL] [Abstract][Full Text] [Related]
10. VIP treatment prevents embryo resorption by modulating efferocytosis and activation profile of maternal macrophages in the CBAxDBA resorption prone model.
Gallino L; Calo G; Hauk V; Fraccaroli L; Grasso E; Vermeulen M; Leirós CP; Ramhorst R
Sci Rep; 2016 Jan; 6():18633. PubMed ID: 26733206
[TBL] [Abstract][Full Text] [Related]
11. VPAC1 and VPAC2 receptor deficiencies negatively influence pregnancy outcome through distinct and overlapping modulations of immune, trophoblast and vascular functions.
Calo G; Hauk V; Vota D; Van C; Condro M; Gallino L; Ramhorst R; Waschek J; Pérez Leirós C
Biochim Biophys Acta Mol Basis Dis; 2023 Feb; 1869(2):166593. PubMed ID: 36328148
[TBL] [Abstract][Full Text] [Related]
12. Vasoactive intestinal peptide induces an immunosuppressant microenvironment in the maternal-fetal interface of non-obese diabetic mice and improves early pregnancy outcome.
Hauk V; Azzam S; Calo G; Gallino L; Paparini D; Franchi A; Ramhorst R; Pérez Leirós C
Am J Reprod Immunol; 2014 Feb; 71(2):120-30. PubMed ID: 24405265
[TBL] [Abstract][Full Text] [Related]
13. VIP contribution to the decidualization program: regulatory T cell recruitment.
Grasso E; Paparini D; Agüero M; Mor G; Pérez Leirós C; Ramhorst R
J Endocrinol; 2014 Apr; 221(1):121-31. PubMed ID: 24492467
[TBL] [Abstract][Full Text] [Related]
14. Trophoblast VIP deficiency entails immune homeostasis loss and adverse pregnancy outcome in mice.
Hauk V; Vota D; Gallino L; Calo G; Paparini D; Merech F; Ochoa F; Zotta E; Ramhorst R; Waschek J; Leirós CP
FASEB J; 2019 Feb; 33(2):1801-1810. PubMed ID: 30204500
[TBL] [Abstract][Full Text] [Related]
15. Control of the inflammatory response during pregnancy: potential role of VIP as a regulatory peptide.
Ramhorst R; Calo G; Paparini D; Vota D; Hauk V; Gallino L; Merech F; Grasso E; Leirós CP
Ann N Y Acad Sci; 2019 Feb; 1437(1):15-21. PubMed ID: 29740848
[TBL] [Abstract][Full Text] [Related]
16. Potential immunomodulatory role of VIP in the implantation sites of prediabetic nonobese diabetic mice.
Roca V; Calafat M; Larocca L; Ramhorst R; Farina M; Franchi AM; Leirós CP
Reproduction; 2009 Oct; 138(4):733-42. PubMed ID: 19633131
[TBL] [Abstract][Full Text] [Related]
17. VIP impairs acquisition of the macrophage proinflammatory polarization profile.
Carrión M; Pérez-García S; Martínez C; Juarranz Y; Estrada-Capetillo L; Puig-Kröger A; Gomariz RP; Gutiérrez-Cañas I
J Leukoc Biol; 2016 Dec; 100(6):1385-1393. PubMed ID: 27381006
[TBL] [Abstract][Full Text] [Related]
18. cAMP activation by PACAP/VIP stimulates IL-6 release and inhibits osteoblastic differentiation through VPAC2 receptor in osteoblastic MC3T3 cells.
Nagata A; Tanaka T; Minezawa A; Poyurovsky M; Mayama T; Suzuki S; Hashimoto N; Yoshida T; Suyama K; Miyata A; Hosokawa H; Nakayama T; Tatsuno I
J Cell Physiol; 2009 Oct; 221(1):75-83. PubMed ID: 19496170
[TBL] [Abstract][Full Text] [Related]
19. Modulation of maternal LIF producers T cells by trophoblast and paternal antigens.
Fraccaroli L; Grasso E; Zeitler E; Lombardi E; Gogorza S; Etchepareborda JJ; Nagle C; Cortelezzi M; Pérez Leirós C; Ramhorst R
Am J Reprod Immunol; 2011 Feb; 65(2):133-45. PubMed ID: 20618183
[TBL] [Abstract][Full Text] [Related]
20. Altered expression of vasoactive intestinal peptide receptors in T lymphocytes and aberrant Th1 immunity in multiple sclerosis.
Sun W; Hong J; Zang YC; Liu X; Zhang JZ
Int Immunol; 2006 Dec; 18(12):1691-700. PubMed ID: 17077178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
